BIOHIT HealthCare is excited to announce an upcoming webinar, 'Current and future trends in inflammatory bowel disease (IBD) therapeutic drug monitoring (TDM)', which will take place on 3 July at 12:30-1:30pm BST.
The BIOHIT team will be joined by Rachel Nice, Section Lead for R&D and Specialist Services at Exeter Clinical Laboratory, and Rebecca Smith, Gastroenterology Specialist Registrar, both from the Royal Devon University Healthcare NHS Foundation Trust, to tackle the burning questions around this topical subject.
The management of IBD is rapidly evolving, driven by recent studies and advances, including the personalised anti-TNF therapy in Crohn’s disease (PANTS study). In this webinar, the expert speakers will explore various topics surrounding TDM, including our current understanding, the development of immunogenicity and importance of early optimisation, as well as how TDM can be used most effectively to enable subcutaneous drug delivery and manage biologics treatment in the first year of therapy. They will also delve into applications beyond anti-TNF therapies, and discuss how this approach may be used alongside pharmaco-multiomics in the future.
This event is an excellent opportunity to gain insights from leading experts in the field, ask questions, and join in the conversation about the future of IBD management with TDM. BIOHIT welcomes healthcare professionals, researchers and anyone interested in the evolving management of IBD to register for this free event.